phorbol 12,13-dibutyrate has been researched along with apigenin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Ahn, HY; Fang, LH; Hong, JT; Kim, TJ; Kim, Y; Lee, CK; Park, YS; Yun, YP; Zhang, YH | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and apigenin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin.
Topics: Animals; Aorta, Thoracic; Apigenin; Cell Division; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Flavonoids; Isometric Contraction; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Phorbol 12,13-Dibutyrate; Rats; Rats, Sprague-Dawley; Thymidine | 2000 |